PCM
WVE icon

Penserra Capital Management’s Wave Life Sciences WVE Stock Holding History

Penserra Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,165
Closed -$5K – 1568
2021
Q3 		$5K Buy
1,165
+30
+3% +$182 ﹤0.01% 1410
2021
Q2 		$7K Buy
1,135
+25
+2% +$163 ﹤0.01% 1300
2021
Q1 		$6K Sell
1,110
-10
-0.9% -$96 ﹤0.01% 1080
2020
Q4 		$8K Buy
1,120
+810
+261% +$6.8K ﹤0.01% 953
2020
Q3 		$2K Buy
+310
New +$3.4K ﹤0.01% 910

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Penserra Capital Management's WVE Position: Q4 2021 in Review

Penserra Capital Management sold out of Wave Life Sciences (WVE) in Q4 2021, closing a stake of 1,165 shares — an estimated $5K sold.

Penserra Capital Management first reported a position in WVE in Q3 2020 and held it in 5 quarters. The position peaked at $8K in Q4 2020. 90 funds tracked by Wall St. Rank hold WVE as of Q4 2021.

  • Penserra Capital Management reported no remaining Wave Life Sciences position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,165 Wave Life Sciences shares in Q4 2021, an estimated $5K.
  • Penserra Capital Management first reported a position in Wave Life Sciences in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's Wave Life Sciences position peaked at $8K in Q4 2020.
  • 90 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.